Literature DB >> 9464394

Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.

R L Brandão1, I M Castro, E A Bambirra, S C Amaral, L G Fietto, M J Tropia, M J Neves, R G Dos Santos, N C Gomes, J R Nicoli.   

Abstract

As is the case for Saccharomyces boulardii, Saccharomyces cerevisiae W303 protects Fisher rats against cholera toxin (CT). The addition of glucose or dinitrophenol to cells of S. boulardii grown on a nonfermentable carbon source activated trehalase in a manner similar to that observed for S.cerevisiae. The addition of CT to the same cells also resulted in trehalase activation. Experiments performed separately on the A and B subunits of CT showed that both are necessary for activation. Similarly, the addition of CT but not of its separate subunits led to a cyclic AMP (cAMP) signal in both S. boulardii and S. cerevisiae. These data suggest that trehalase stimulation by CT probably occurred through the cAMP-mediated protein phosphorylation cascade. The requirement of CT subunit B for both the cAMP signal and trehalase activation indicates the presence of a specific receptor on the yeasts able to bind to the toxin, a situation similar to that observed for mammalian cells. This hypothesis was reinforced by experiments with 125I-labeled CT showing specific binding of the toxin to yeast cells. The adhesion of CT to a receptor on the yeast surface through the B subunit and internalization of the A subunit (necessary for the cAMP signal and trehalase activation) could be one more mechanism explaining protection against the toxin observed for rats treated with yeasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464394      PMCID: PMC106083     

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  19 in total

1.  Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea.

Authors:  J K Chia; S M Chan; H Goldstein
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

Review 2.  Fermentable sugars and intracellular acidification as specific activators of the RAS-adenylate cyclase signalling pathway in yeast: the relationship to nutrient-induced cell cycle control.

Authors:  J M Thevelein
Journal:  Mol Microbiol       Date:  1991-06       Impact factor: 3.501

3.  Treatment of Clostridium difficile diarrhoea with brewer's yeast.

Authors:  D Schellenberg; A Bonington; C M Champion; R Lancaster; S Webb; J Main
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

4.  Cyclic AMP and the stimulation of trehalase activity in the yeast Saccharomyces cerevisiae by carbon sources, nitrogen sources and inhibitors of protein synthesis.

Authors:  J M Thevelein; M Beullens
Journal:  J Gen Microbiol       Date:  1985-12

5.  Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.

Authors:  D Czerucka; I Roux; P Rampal
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

6.  Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

Authors:  C Pothoulakis; C P Kelly; M A Joshi; N Gao; C J O'Keane; I Castagliuolo; J T Lamont
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

7.  Protective effect of Saccharomyces boulardii against the cholera toxin in rats.

Authors:  R S Dias; E A Bambirra; M E Silva; J R Nicoli
Journal:  Braz J Med Biol Res       Date:  1995-03       Impact factor: 2.590

8.  Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

Authors:  J P Buts; G Corthier; M Delmee
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

9.  Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.

Authors:  C M Surawicz; G W Elmer; P Speelman; L V McFarland; J Chinn; G van Belle
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

10.  [Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].

Authors:  N Vidon; B Huchet; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1986-01
View more
  23 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  A Mutation in PGM2 Causing Inefficient Galactose Metabolism in the Probiotic Yeast Saccharomyces boulardii.

Authors:  Jing-Jing Liu; Guo-Chang Zhang; In Iok Kong; Eun Ju Yun; Jia-Qi Zheng; Dae-Hyuk Kweon; Yong-Su Jin
Journal:  Appl Environ Microbiol       Date:  2018-05-01       Impact factor: 4.792

3.  Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin.

Authors:  Bärbel Stecher; Andrew J Macpherson; Siegfried Hapfelmeier; Marcus Kremer; Thomas Stallmach; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Yeasts from kefir grains: isolation, identification, and probiotic characterization.

Authors:  Gabriela Diosma; David E Romanin; María F Rey-Burusco; Alejandra Londero; Graciela L Garrote
Journal:  World J Microbiol Biotechnol       Date:  2013-07-04       Impact factor: 3.312

5.  Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).

Authors:  M J McCullough; K V Clemons; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

6.  Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.

Authors:  Flaviano S Martins; Guillaume Dalmasso; Rosa M E Arantes; Anne Doye; Emmanuel Lemichez; Patricia Lagadec; Veronique Imbert; Jean-François Peyron; Patrick Rampal; Jacques R Nicoli; Dorota Czerucka
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

7.  Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.

Authors:  Karen L Mumy; Xinhua Chen; Ciarán P Kelly; Beth A McCormick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-21       Impact factor: 4.052

8.  The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice.

Authors:  Mehmet Faruk Geyik; Mustafa Aldemir; Salih Hosoglu; Celal Ayaz; Selda Satilmis; Huseyin Buyukbayram; Omer Faruk Kokoglu
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

9.  Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.

Authors:  Johnathan Sheele; Jessica Cartowski; Angela Dart; Arjun Poddar; Shikha Gupta; Eric Stashko; Bhaskara S Ravi; Crawford Nelson; Ajay Gupta
Journal:  Pathog Glob Health       Date:  2015-08-11       Impact factor: 2.894

10.  Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.

Authors:  S Thomas; I Przesdzing; D Metzke; J Schmitz; A Radbruch; D C Baumgart
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.